Randomized double-blind placebo-controlled Trial of Perhexiline in Heart Failure With Preserved Ejection Fraction Syndrome

References

• Mosterd A , HoesAW . Clinical epidemiology of heart failure . Heart93 ( 9 ), 1137 – 1146 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Mann DL , BristowMR . Mechanisms and models in heart failure: the biomechanical model and beyond . Circulation111 ( 21 ), 2837 – 2849 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Aurigemma GP . Diastolic heart failure – a common and lethal condition by any name . N. Engl. J. Med.355 ( 3 ), 308 – 310 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Bhatia RS , TuJV, LeeDSet al. Outcome of heart failure with preserved ejection fraction in a population-based study . N. Engl. J. Med.355 ( 3 ), 260 – 269 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Owan TE , HodgeDO, HergesRM, JacobsenSJ, RogerVL, RedfieldMM . Trends in prevalence and outcome of heart failure with preserved ejection fraction . N. Engl. J. Med.355 ( 3 ), 251 – 259 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Desai A . Current understanding of heart failure with preserved ejection fraction . Curr. Opin Cardiol.22 ( 6 ), 578 – 585 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Gaasch WH , LittleWC . Assessment of left ventricular diastolic function and recognition of diastolic heart failure . Circulation116 ( 6 ), 591 – 593 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Zile MR , BaicuCF, GaaschWH . Diastolic heart failure – abnormalities in active relaxation and passive stiffness of the left ventricle . N. Engl. J. Med.350 ( 19 ), 1953 – 1959 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Paulus WJ , TschöpeC, SandersonJEet al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology . Eur. Heart J.28 ( 20 ), 2539 – 2550 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Medeiros A , RolimNPL, OliveiraRSFet al. Exercise training delays cardiac dysfunction and prevents calcium handling abnormalities in sympathetic hyperactivity-induced heart failure mice . J. Appl. Physiol.104 ( 1 ), 103 – 109 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Hinken AC , KorteFS, McDonaldKS . Porcine cardiac myocyte power output is increased after chronic exercise training . J. Appl. Physiol.101 ( 1 ), 40 – 46 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Phan TT , AbozguiaK, Nallur ShivuGet al. Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency . J. Am. Coll. Cardiol.54 ( 5 ), 402 – 409 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Abozguia K , ElliottP, McKennaWet al. Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy . Circulation122 ( 16 ), 1562 – 1569 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Ashrafian H , HorowitzJD, FrenneauxMP . Perhexiline . Cardiovasc. Drug Rev.25 ( 1 ), 76 – 97 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Yusuf S , PfefferMA, SwedbergKet al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial . Lancet362 ( 9386 ), 777 – 781 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Cleland JGF , TenderaM, AdamusJ, FreemantleN, PolonskiL, TaylorJ . The Perindopril in Elderly People with Chronic Heart Failure (PEP-CHF) study . Eur. Heart J.27 ( 19 ), 2338 – 2345 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Edelmann F , WachterR, SchmidtAGet al. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial . JAMA309 ( 8 ), 781 – 791 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kosmala W , HollandDJ, RojekA, WrightL, Przewlocka-KosmalaM, MarwickTH . Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial . J. Am. Coll. Cardiol.62 ( 15 ), 1330 – 1338 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lele SS , ThomsonHL, SeoH, BelenkieI, McKennaWJ, FrenneauxMP . Exercise capacity in hypertrophic cardiomyopathy: role of stroke volume limitation, heart rate, and diastolic filling characteristics . Circulation92 ( 10 ), 2886 – 2894 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Shivu GN , AbozguiaK, PhanTT, AhmedI, HenningA, FrenneauxM . 31P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: experiences at 3 T . Eur. J. Radiol.73 ( 2 ), 255 – 259 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Naressi A , CouturierC, CastangI, De BeerR, Graveron-DemillyD . Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals . Comput. Biol. Med.31 ( 4 ), 269 – 286 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Bottomley PA , HardyCJ, WeissRG . Correcting human heart 31P NMR spectra for partial saturation. Evidence that saturation factors for PCr/ATP are homogeneous in normal and disease states . J. Magn. Reson.95 ( 2 ), 341 – 355 ( 1991 ).
   Web of Science ®Google Scholar
• Conway MA , BottomleyPA, OuwerkerkR, RaddaGK, RajagopalanB, CooperR . Mitral regurgitation: Impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans . Circulation97 ( 17 ), 1716 – 1723 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Pfeffer MA , McKinlayS, PittB . Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) . Circulation128, 2709 ( 2013 ).
   Web of Science ®Google Scholar